About Roka Bioscience
Roka Bioscience, Inc. is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using culture-based assays, immunochemical-based assays and molecular-based assays. The Company sells its Atlas Detection Assays and related consumable supplies for use with its Atlas instruments. The Company's Atlas instrument is an automated molecular diagnostic testing and a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single, integrated platform.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Laboratories & Research
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: ROKA
- Previous Close: $4.44
- 50 Day Moving Average: $4.59
- 200 Day Moving Average: $3.47
- 52-Week Range: $3.66 - $16.00
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -0.96
- P/E Growth: 0.00
- Market Cap: $7.84M
- Outstanding Shares: 1,841,000
- Beta: 1.95
- Net Margins: -487.61%
- Return on Equity: -89.22%
- Return on Assets: -50.43%
Companies Related to Roka Bioscience:
- Current Ratio: 2.60%
- Quick Ratio: 2.36%
What is Roka Bioscience's stock symbol?
Roka Bioscience trades on the NASDAQ under the ticker symbol "ROKA."
Where is Roka Bioscience's stock going? Where will Roka Bioscience's stock price be in 2017?
2 analysts have issued twelve-month price objectives for Roka Bioscience's stock. Their predictions range from $1.00 to $10.00. On average, they expect Roka Bioscience's share price to reach $5.50 in the next year.
When will Roka Bioscience announce their earnings?
Roka Bioscience is scheduled to release their next quarterly earnings announcement on Thursday, March, 2nd 2017.
Who owns Roka Bioscience stock?
Roka Bioscience's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Orbimed Advisors LLC (48.53%), Sabby Healthcare Master Fund, Ltd (7.30%), Armistice Capital LLC (12.82%) and Birchview Capital LP (2.54%).
Who sold Roka Bioscience stock? Who is selling Roka Bioscience stock?
Roka Bioscience's stock was sold by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC and Birchview Capital LP.
Who bought Roka Bioscience stock? Who is buying Roka Bioscience stock?
Roka Bioscience's stock was purchased by a variety of institutional investors in the last quarter, including Armistice Capital LLC.
How do I buy Roka Bioscience stock?
Shares of Roka Bioscience can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Roka Bioscience stock cost?
One share of Roka Bioscience stock can currently be purchased for approximately $4.26.